David E. Levy

NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY.

DOV Pharmaceutical, Inc. discovers and develops novel drugs. It focuses on the development of novel product candidates for disorders of the central nervous system, or CNS. It have drug development programs that are at the preclinical, Phase I and Phase II clinical stages, including DOV 21,947 (in a Phase II clinical trial for depression), DOV 102,677 (which has completed a Phase I clinical trial) and a preclinical discovery program in reuptake inhibitors and GABA modulators. The company was founded by Arnold S. Lippa in May, 1995 and is headquartered in Somerset, NJ.

Part of Neurobiological Technologies, Inc., Empire Pharmaceuticals, Inc. develops late-stage perfusion therapy for use in the treatment of acute ischemic stroke. The company is based in Newbury Park, CA. The company was founded by Stephen J. Petti, David E. Levy. Empire Pharmaceuticals was acquired by Neurobiological Technologies, Inc. on July 15, 2004 for $22.91 million.